Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_assertion type Assertion NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_head.
- NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_assertion description "[High prevalence of BRAF mutations in thyroid cancer is genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_provenance.
- NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_assertion evidence source_evidence_literature NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_provenance.
- NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_assertion SIO_000772 12670889 NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_provenance.
- NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_assertion wasDerivedFrom lhgdn-20090331 NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_provenance.
- NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_assertion wasGeneratedBy ECO_0000203 NP114106.RAdtMdeMmN9bcwxO4U--20GZ2CKLjpy48i6_aBIqxq-AE130_provenance.